Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective beta-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure based design and in vivo reduction of amyloid beta-peptides.
Rueeger, H., Lueoend, R., Machauer, R., Veenstra, S.J., Jacobson, L.H., Staufenbiel, M., Desrayaud, S., Rondeau, J.M., Mobitz, H., Neumann, U.(2013) Bioorg Med Chem Lett 23: 5300-5306
- PubMed: 23981898 
- DOI: https://doi.org/10.1016/j.bmcl.2013.07.071
- Primary Citation of Related Structures:  
4LXA, 4LXK, 4LXM - PubMed Abstract: 
Previous structure based optimization in our laboratories led to the identification of a novel, high-affinity cyclic sulfone hydroxyethylamine-derived inhibitor such as 1 that lowers CNS-derived Aβ following oral administration to transgenic APP51/16 mice ...